Nov 12 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND
ANNOUNCES
EXPANDED PORTFOLIO OF PHAGE THERAPY CANDIDATES
    * BIOMX INC - ANNOUNCES EXPANDED PORTFOLIO OF PHAGE THERAPY
CANDIDATES
    * BIOMX INC - EXPECTS TO INITIATE A PHASE 2 COSMETIC
CLINICAL
STUDY OF PHAGE THERAPY BX001 IN Q1 OF 2021
    * BIOMX INC -  RESULTS EXPECTED IN Q2 OF 2021 FROM PHASE 2
COSMETIC CLINICAL STUDY OF PHAGE THERAPY BX001
    * BIOMX INC - CASH, EQUIVALENTS, SHORT-TERM DEPOSITS ARE
EXPECTED
TO BE SUFFICIENT TO FUND CURRENT OPERATING PLAN THROUGH MID-2022

Source text for Eikon:  ID:nBw7cMjPla 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))